Viewing Study NCT05919212


Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2025-12-31 @ 9:43 PM
Study NCT ID: NCT05919212
Status: RECRUITING
Last Update Posted: 2024-04-15
First Post: 2023-05-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab Deruxtecan (T-DXd): Tailoring Treatment and Companion Diagnostics (CDx) by Liquid Biopsy
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module